Clinical Trial Update: Clinical Study of YYJD Decoction Combined With Gefitinib in Advanced Pulmonary Adenocarcinoma [Phase 3]

View source ↗

Summary

A Phase 3 clinical trial evaluating YYJD Decoction in combination with gefitinib for advanced pulmonary adenocarcinoma is ongoing or not yet reported.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Lung Cancer
• Pulmonary Adenocarcinoma

Drugs mentioned

• Gefitinib (Gefitinib)
• YYJD Decoction

Snippet

Sponsor: Shanghai University of Traditional Chinese Medicine | Conditions: Cancer | Phase 3 | Status: UNKNOWN